Symptoms of endocrine treatment and outcome in the BIG 1-98 study. - Wikidata - awgldk - TriplyDB

Symptoms of endocrine treatment and outcome in the BIG 1-98 study.

Symptoms of endocrine treatment and outcome in the BIG 1-98 study.

http://www.wikidata.org/entity/Q37553885

about

Stapled BIG3 helical peptide ERAP potentiates anti-tumour activity for breast cancer therapeutics.Status of adjuvant endocrine therapy for breast cancer.Association between treatment toxicity and outcomes in oncology clinical trials Treatment-associated musculoskeletal and vasomotor symptoms and relapse-free survival in the NCIC CTG MA.27 adjuvant breast cancer aromatase inhibitor trial.Safety of aromatase inhibitor therapy in breast cancer.Aromatase inhibitor induced musculoskeletal syndrome: a significant problem with limited treatment options.Prognostic value of endocrine treatment-related symptoms in patients with breast cancer: a meta-analysis.Predictive Value of Early Skin Rash in Cetuximab-Based Therapy of Advanced Biliary Tract Cancer.Are we ready to change clinical practice after the 'soft and text' results?Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial.Endocrine Treatment-Related Symptoms and Patient Outcomes in Breast Cancer: A Meta-Analysis.

P2860

Q33687329-FD29539A-CF16-4865-A51A-7AFB789C87C0 Q33739138-510EF3C7-5260-419B-9C98-1DC41CAB6B76 Q34395352-9AB72E60-F200-439F-B10C-13CEFEE92A16 Q34903656-BB6AFCD3-34C3-460C-8B07-3B19EABBA237 Q38522924-72F00FB9-CEC7-4162-82B9-AC3EB76143E6 Q38629979-8E17B898-A7B5-445B-802D-5F63AA605772 Q38963111-4B8F1E0D-774C-41CF-ACF1-2575834B5493 Q48214785-4E8FA3A9-D414-4CF8-9923-E7989D1977FE Q48376613-9BB5C6D4-0AFC-4C79-9C00-90FACDEC79CF Q51072176-B670B038-3391-4004-AA36-4FE826F4F82C Q54966058-3C727E5B-9F81-4C43-8D99-A439C2A6697D

P2860

Symptoms of endocrine treatment and outcome in the BIG 1-98 study.

http://www.wikidata.org/entity/Q37553885

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 05 December 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Symptoms of endocrine treatment and outcome in the BIG 1-98 study.

@en

Symptoms of endocrine treatment and outcome in the BIG 1-98 study.

@nl

type

label

Symptoms of endocrine treatment and outcome in the BIG 1-98 study.

@en

Symptoms of endocrine treatment and outcome in the BIG 1-98 study.

@nl

prefLabel

Symptoms of endocrine treatment and outcome in the BIG 1-98 study.

@en

Symptoms of endocrine treatment and outcome in the BIG 1-98 study.

@nl

P1433

Q37553885-71006680-A2C0-4EFB-8C90-0DA6E30ED400

P1476

Q37553885-B1B8F7CA-F7B0-4CE3-9600-504FE7BF248F

P2093

Q37553885-0707DFB8-5C3B-490B-958F-EC7285C3425C

Q37553885-12859ABA-2986-4347-81A8-FE59C8052704

Q37553885-17E42CFA-AD20-46BA-978B-60431954D004

Q37553885-20ADA8C1-7E11-4463-A5E2-B1AF0E862464

Q37553885-21091A1C-F3D9-4CF6-A903-36D8F1DF2A08

Q37553885-21AA0F98-6F00-4B94-A179-175DF62716F5

Q37553885-34224CA1-A082-4ACA-A643-4CD24FCD0C43

Q37553885-4A5B51A7-1023-413B-BF4F-B55773209450

Q37553885-95FB0661-E85C-4878-9E6D-1AF30FB6E976

Q37553885-96F05EC3-7F01-443C-96AD-AA3A029DDEB0

P2860

Q37553885-1B1E1C8E-38B8-4BF7-864D-62F9565756DD

Q37553885-1C986425-83DB-4AB4-AC3F-9F2FACB07888

Q37553885-1F65709B-0E0F-496E-A91E-A73DF25BBF34

Q37553885-201F884E-1356-4308-B944-CD80CEF3527A

Q37553885-23360FC1-B787-4653-87DE-308EE9DCB3B8

Q37553885-269EDBC3-905D-4CCA-8947-F3965520F160

Q37553885-2D733462-CF3F-4C73-B37B-82F24620331E

Q37553885-467AC88E-A6E1-468E-AF46-5537FAE19592

Q37553885-4A2544D1-541C-4DEB-B638-C095523F61DE

Q37553885-4F00756B-E61E-4353-9A44-08F261D2C64A

P2888

Q37553885-C3B1EEB2-098D-46B3-A309-2607872EB676

P304

Q37553885-D04842E4-9980-4EF3-A3E6-8F844826EC4F

P31

Q37553885-14359BC1-4BA7-4537-8A18-D70C7C98CAB8

P356

Q37553885-FA2531C6-034D-450C-9A6D-4969BDDD362D

P407

Q37553885-5DE9C5C0-4B9A-4757-B16B-472FCC0524C1

P433

Q37553885-FE3FA62E-1013-413B-B8F2-82E105FB2383

P478

Q37553885-64108448-F4B2-43E3-9AD2-63D11C6C36E0

P50

Q37553885-40E43C3F-2779-4D1D-B8E1-EFD3AD71912A

Q37553885-F93FE90C-43A2-412E-852C-E72A212849A9

P577

Q37553885-E7541A11-E82E-45A2-A25E-6B7129C31ABC

P5875

Q37553885-475B1B22-EADE-4A0B-9FAF-22BA877BC1E5

P698

Q37553885-29B1788D-355B-499B-A943-6A94A19F69A3

P932

Q37553885-DDA8F8A2-4867-4499-82F4-557CE7C0E056

P356

S10549-013-2792-7

P1433

Breast Cancer Research and Treatment

P1476

Symptoms of endocrine treatment and outcome in the BIG 1-98 study

@en

P2093

A Giobbie-Hurder

http://www.w3.org/2001/XMLSchema#string

A Goldhirsch

http://www.w3.org/2001/XMLSchema#string

A S Coates

http://www.w3.org/2001/XMLSchema#string

B Ejlertsen

http://www.w3.org/2001/XMLSchema#string

B F Cole

http://www.w3.org/2001/XMLSchema#string

B Thürlimann

http://www.w3.org/2001/XMLSchema#string

BIG 1-98 Collaborative and International Breast Cancer Study Groups

http://www.w3.org/2001/XMLSchema#string

H Bonnefoi

http://www.w3.org/2001/XMLSchema#string

I Láng

http://www.w3.org/2001/XMLSchema#string

I Smith

http://www.w3.org/2001/XMLSchema#string

P2860

Nonparametric Estimation from Incomplete Observations

Exact inference for categorical data: recent advances and continuing controversies.

Antiemetics: American Society of Clinical Oncology clinical practice guideline update.

Evaluation of survival data and two new rank order statistics arising in its consideration.

Minireview: aromatase and the regulation of estrogen biosynthesis--some new perspectives.

CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment.

Genome-wide associations and functional genomic studies of musculoskeletal adverse events in women receiving aromatase inhibitors.

Association of functional polymorphisms in CYP19A1 with aromatase inhibitor associated arthralgia in breast cancer survivors.

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

Aromatase inhibitor-associated bone and musculoskeletal effects: new evidence defining etiology and strategies for management

P2888

s10549-013-2792-7

P304

159-169

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10549-013-2792-7

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

143

http://www.w3.org/2001/XMLSchema#string

P50

Andrew M. Wardley

P577

2013-12-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259634390

http://www.w3.org/2001/XMLSchema#string

P698

24305979

http://www.w3.org/2001/XMLSchema#string

P932

3913479

http://www.w3.org/2001/XMLSchema#string